new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing

Merck will soon market new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing.

The new tabs come in two strengths...35 and 70 mg.

Patients taking 5 mg/d to prevent osteoporosis use the 35 mg tab.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote